Morgane Cleirec

Nantes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience.

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors: The SACHA-France experience.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 16, 2026

Characterization of a Novel SREBF1::CIC Transcript in a Neonatal Soft Tissue Sarcoma.

Characterization of a Novel SREBF1::CIC Transcript in a Neonatal Soft Tissue Sarcoma.

Journal: Pediatric blood & cancer
Published: April 23, 2025

Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France Experience.

Centralized Investigator Review of Radiological and Functional Imaging Reports in Real-World Oncology Studies: The SACHA-France Experience.

Journal: Pediatric blood & cancer
Published: October 03, 2024

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.

Journal: European journal of cancer (Oxford, England : 1990)
Published: September 27, 2023

A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?

A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?

Journal: Cancer treatment reviews
Published: July 22, 2023

Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study.

Measuring Safety and Outcomes for the Use of Compassionate and Off-Label Therapies for Children, Adolescents, and Young Adults With Cancer in the SACHA-France Study.

Journal: JAMA network open
Published: July 03, 2023

Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.

Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.

Journal: International journal of cancer
Published: June 01, 2022

Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience.

Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience.

Journal: Pediatric blood & cancer
Published: April 24, 2022

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?

Journal: Cancers
Published: February 24, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026